Who are ARS Pharmaceuticals, Inc.'s main suppliers?

ARS Pharmaceuticals, Inc. (SPRY) key suppliers include: Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., ORANY, ORANY. View the full supplier network at chainsifter.com/chain/SPRY.

Who are ARS Pharmaceuticals, Inc.'s major customers?

ARS Pharmaceuticals, Inc. (SPRY) key customers include: CUSTOMER, ALK-U-S, Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., ORANY and 1 more. View the full customer network at chainsifter.com/chain/SPRY.

What sector is ARS Pharmaceuticals, Inc. in?

ARS Pharmaceuticals, Inc. (SPRY) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

SPRY Supply Chain: ARS Pharmaceuticals, Inc. Supplier List & 13 Relationships

4Suppliers

6Customers

3Debt Items

20Related Chains

ARS Pharmaceuticals, Inc. Suppliers

Ticker	Name	Confidence	Evidence
AMRX	Amneal Pharmaceuticals, Inc.	72%	. We believe that NARCAN’s widespread use clearly demonstrates market uptake in response to the advantages of an intranasal product via proven device over injection, considering in particular that NA…
AMRX	Amneal Pharmaceuticals, Inc.	72%	Reciprocal relationship from AMRX graph: Reciprocal relationship from SPRY graph: . We believe that NARCAN’s widespread use clearly demonstrates market uptake in response to the advantages of an intr…
ORANY	ORANY	72%	tory concern. We may terminate the ALK Agreement in the event ALK makes certain challenges to certain of our patents. Prior to a change of control and outside of a set period of time after which we c…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from SPRY graph: tory concern. We may terminate the ALK Agreement in the event ALK makes certain challenges to certain of our patents…

ARS Pharmaceuticals, Inc. Customers

Ticker	Name	Confidence	Evidence
CUSTOMER	CUSTOMER	92%	For the three months ended March 31, 2026 , three customers accounted for 99 % of revenue under supply agreements
ALK-U-S	ALK-U-S	90%	we granted ALK U.S. a non-exclusive, royalty-free license to use the neffy trademarks and copyrights and the ARS house marks in the U.S. solely in connection with promoting neffy
AMRX	Amneal Pharmaceuticals, Inc.	72%	. We believe that NARCAN’s widespread use clearly demonstrates market uptake in response to the advantages of an intranasal product via proven device over injection, considering in particular that NA…
AMRX	Amneal Pharmaceuticals, Inc.	72%	Reciprocal relationship from AMRX graph: Reciprocal relationship from SPRY graph: . We believe that NARCAN’s widespread use clearly demonstrates market uptake in response to the advantages of an intr…
ORANY	ORANY	72%	tory concern. We may terminate the ALK Agreement in the event ALK makes certain challenges to certain of our patents. Prior to a change of control and outside of a set period of time after which we c…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from SPRY graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from SPRY graph: Reciprocal relationship from ORAN…

ARS Pharmaceuticals, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
SPRY-DEBT	Debt stack $171.2M	90%	Market cache reports total debt of $171.2M.
SPRY-DEBT-12715	Warrants outstanding: 223000	90%	xbrl warrant detail from xbrl 2023-12-31.
SPRY-DEBT-12716	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2022-12-31.

ARS Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ARS Pharmaceuticals, Inc..

ARS Pharmaceuticals, Inc. Ownership

Holder	Name	Confidence	Evidence
SPRY-OWNER-RA-CAPITAL-MANAGEMENT-L-P	RA CAPITAL MANAGEMENT, L.P.	90%	13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 204 tracked holders.

ARS Pharmaceuticals, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
AMAZON	AMAZON	100.00	2
SKYW	SkyWest, Inc.	100.00	2
AMZN	Amazon.com, Inc.	100.00	2
ORANY	ORANGE	100.00	1	['customer', 'supplier']
AMRX	Amneal Pharmaceuticals, Inc.	100.00	1	['customer', 'supplier']
ASRT	Assertio Holdings, Inc.	100.00	2
VLRS	Controladora Vuela Compañía de Aviación, S.A.B. de C.V.	100.00	2
ALK	Alaska Air Group, Inc.	63.48	1	['receiving']
CANF	Can-Fite BioPharma Ltd.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
ALKS	Alkermes plc	50.00	2
BLTE	Belite Bio, Inc	50.00	2
D	Dominion Energy, Inc.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
EQR	Equity Residential	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2

ARS Pharmaceuticals, Inc. Supply Chain